Spectranetics Unfazed By Study On Laser Use For In-Stent Restenosis

Spectranetics is confident that clinical trials for the firm's CVX-300 excimer laser will demonstrate the device to be effective in treating in-stent restenosis despite unfavorable results reported in a recently completed independent study.

More from Archive

More from Medtech Insight